<?xml version="1.0" encoding="UTF-8"?>
<p id="p0190">With regards to infection risk, a case-control study by Damiani etÂ al
 <xref rid="bib74" ref-type="bibr">
  <sup>74</sup>
 </xref> evaluated 1193 patients with psoriasis and identified only 16 cases of COVID-19 from February 21 to April 9, 2020. Compared with the general population of Lombardy, patients on biologics had a higher risk of testing positive for COVID-19 (OR, 3.43; 95% CI, 2.25-5.73) and hospitalization (OR, 3.59; 95% CI, 1.49-8.63).
</p>
